产品详情
查看大图

  • 产品名称：Neuramidase(C-Term)Peptide

  • 产品型号：
  • 产品厂商：PromoCell
  • 产品文档：
你添加了1件商品 查看购物车
简单介绍：
Neuramidase(C-Term)Peptide
详情介绍：
Blocked Antibody anti-Neuraminidase, NEU (NEU) (C-Term) antibody (ABIN1002324)
Characteristics 15 amino acids near the carboxy terminus of Avian Influenza A (H5N1) neuraminidase.
Application Notes The peptide is used for blocking the activity of the avian influenza neuraminidase antibody . It usually blocks the antibody activity completely in ELISA assays by incubating the peptide with equal volume of antibody for 30 min at 37º
Restrictions For Research Use only
Format Liquid
Concentration 200 µg/mL
Buffer Supplied in PBS pH 7.2 (10 mM NaH₂PO₄, 10 mM Na₂HPO₄, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice For products with volumes of 200 μl or less, we recommend gently tapping the vial on a hard surface or briefly centrifuging the vial in a tabletop centrifuge to dislodge any liquid in the container’s cap. The peptide solution should be gently mixed before use.
Storage -20 °C
Storage Comment Store at -20°C, stable for one year.
Expiry Date 12 months
Background publications Vogel, Fitzgerald, Fenton: "TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression." in: Molecular interventions, Vol. 3, Issue 8, pp. 466-77, 2004 (PubMed).

Takeda, Kaisho, Akira: "Toll-like receptors." in: Annual review of immunology, Vol. 21, pp. 335-76, 2003 (PubMed).

Wald, Qin, Zhao, Qian, Naramura, Tian, Towne, Sims, Stark, Li: "SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling." in: Nature immunology, Vol. 4, Issue 9, pp. 920-7, 2003 (PubMed).

Product cited in: Sweet, Leung, Kang, Sogaard, Schulz, Trajkovic, Campbell, Xu, Liew: "A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 166, Issue 11, pp. 6633-9, 2001 (PubMed).